“Incremental Risk of Adverse Events With Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s320. Accessed May 25, 2026. https://skin.dermsquared.com/skin/article/view/2401.